ALB and Hypoalbuminemia: Similarly, the PK of dalbavancin, oritavancin, tedizolid, and delafloxacin is likely to change significantly in patients with severe hypoalbuminemia (i.e., serum albumin < 2 g/dL), but no data are available from the literature in this clinical context.